CCND1 and hepatocellular carcinoma: In our screening, we observed that CCND1 expression was reduced by sorafenib alone and increasingly more by SOR+CLX treatment especially in Huh7 cells, suggesting that in some HCC cell types these drugs might also act through inhibition of this important regulator of cell proliferation.